Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

112

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	145,946 L.L
N03AX18	VIMPAT	B	Lacosamide - 10mg/ml	10mg/ml	Injectable solution	13,225,715 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	151,692 L.L
N03AX18	TREPADIO	G	Lacosamide - 200mg/20ml	200mg/20ml	Injectable solution	9,569,390 L.L
B03BA01	CYNOVIT-JULPHAR	G	Vitamin B12 - 1mg/ml	1mg/ml	Injectable solution	167,980 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	164,333 L.L
B03BA01	JECTIN-12	G	Cyanocobalamin - 1000mcg/1ml	1000mcg/1ml	Injectable solution	567,102 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	688,359 L.L
B03BA05	COBAL	G	Mecobalamine - 500mcg/ml	500mcg/ml	Injectable solution	1,128,828 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	144,797 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	182,720 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable solution	L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	209,151 L.L
L01FG01	BEVACIREL	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable solution	L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	222,941 L.L
L04AB01	ETANERREL	BioTech	Etanercept - 25mg/0.5ml	25mg/0.5ml	Injectable solution	L.L
A11CC05	DIBASE	G	Vitamin D3 - 100,000IU/ml	100,000IU/ml	Injectable solution	354,774 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	181,570 L.L
M01AE17	KETESSE	B	Dexketoprofen (trometamol) - 50mg/2ml	50mg/2ml	Injectable solution	435,405 L.L
A10AD06	RYZODEG	BioTech	Insulin degludec - 70%, Insulin aspart - 30%	100IU/ml	Injectable solution	7,058,661 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 2,000IU/ml	2,000IU/ml	Injectable solution	6,803,873 L.L
B05XA03	0.9% SODIUM CHLORIDE INJECTION USP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	141,349 L.L
M01AE17	DEXIREN	G	Dexketoprofen - 50mg/2ml	50mg/2ml	Injectable solution	467,657 L.L
B03XA01	EPOMAX	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 2000UI/ml	2000UI/ml	Injectable solution	7,849,606 L.L
B05XA03	CHLORURE DE SODIUM 0.9 pour cent Renaudin	G	Sodium chloride - 0.9%	0.9%	Injectable solution	385,683 L.L
M01AE17	NORMODEX	G	Dexketoprofen (trometamol) - 50mg/2ml	50mg/2ml	Injectable solution	329,241 L.L
A11DB	NEUROBION	B	Vitamin B12 - 1000mcg, Vitamin B6 - 100mg, Vitamin B1 - 100mg		Injectable solution	545,600 L.L
B03XA01	BINOCRIT	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4,000IU/0.4ml	4,000IU/0.4ml	Injectable solution	5,582,795 L.L
B05XA03	CHLORURE DE SODIUM PROAMP	G	Sodium chloride - 0.9%	0.9%	Injectable solution	1,104,639 L.L
A11DB	NEUROBION	B	Vitamin B12 - 1000mcg, Vitamin B6 - 100mg, Vitamin B1 - 100mg		Injectable solution	287,582 L.L

...

112

...